These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 10969596)
1. [Correlation between DNA topoisomerase II alpha expression and sensitivity to etoposide in human glioma cell lines]. Hao YJ; Natsume A; Mizuno M; Taniguchi K; Wakabayashi T; Yoshida J Gan To Kagaku Ryoho; 2000 Aug; 27(9):1403-9. PubMed ID: 10969596 [TBL] [Abstract][Full Text] [Related]
2. Induction of resistance to etoposide and adriamycin in a human glioma cell line treated with antisense oligodeoxynucleotide complementary to the messenger ribonucleic acid of deoxyribonucleic acid topoisomerase II alpha. Kuriyama M; Tsutsui K; Tsutsui K; Ono Y; Tamiya T; Matsumoto K; Furuta T; Ohmoto T Neurol Med Chir (Tokyo); 1997 Sep; 37(9):655-61; discussion 661-2. PubMed ID: 9330528 [TBL] [Abstract][Full Text] [Related]
3. Changes in subcellular distribution of topoisomerase IIalpha correlate with etoposide resistance in multicell spheroids and xenograft tumors. Oloumi A; MacPhail SH; Johnston PJ; Banáth JP; Olive PL Cancer Res; 2000 Oct; 60(20):5747-53. PubMed ID: 11059769 [TBL] [Abstract][Full Text] [Related]
4. Drastic reduction of topoisomerase II alpha associated with major acquired resistance to topoisomerase II active agents but minor perturbations of cell growth. Hashimoto S; Chatterjee S; Ranjit GB; Bao C; Ford J; Ganapathi R; Berger SJ; Berger NA Oncol Res; 1995; 7(7-8):407-16. PubMed ID: 8747604 [TBL] [Abstract][Full Text] [Related]
5. Transfection of a human topoisomerase II alpha gene into etoposide-resistant human breast tumor cells sensitizes the cells to etoposide. Asano T; An T; Zwelling LA; Takano H; Fojo AT; Kleinerman ES Oncol Res; 1996; 8(3):101-10. PubMed ID: 8823806 [TBL] [Abstract][Full Text] [Related]
6. [Expression of DNA topoisomerases (I, II alpha, II beta) mRNA in etoposide- and mAMSA-resistant cell lines]. Matsumoto Y; Takano H; Nagao S; Iglesias A; Fojo T Gan To Kagaku Ryoho; 1997 Dec; 24(15):2265-9. PubMed ID: 9422071 [TBL] [Abstract][Full Text] [Related]
7. Decreased DNA topoisomerase II alpha expression and cold-sensitive growth in a mouse mammary cancer cell line resistant to etoposide and doxorubicin. Kawanami K; Nakamura T; Ono M; Kusano T; Okada K; Kikuchi A; Adachi N; Kohno K; Higashi K; Kuwano M Oncol Res; 1996; 8(5):197-206. PubMed ID: 8884812 [TBL] [Abstract][Full Text] [Related]
8. Enhanced etoposide sensitivity following adenovirus-mediated human topoisomerase IIalpha gene transfer is independent of topoisomerase IIbeta. Zhou Z; Zwelling LA; Ganapathi R; Kleinerman ES Br J Cancer; 2001 Sep; 85(5):747-51. PubMed ID: 11531262 [TBL] [Abstract][Full Text] [Related]
9. Topoisomerase II activities in AML and their correlation with cellular sensitivity to anthracyclines and epipodophyllotoxines. Gieseler F; Glasmacher A; Kämpfe D; Wandt H; Nuessler V; Valsamas S; Kunze J; Wilms K Leukemia; 1996 Jul; 10(7):1177-80. PubMed ID: 8683999 [TBL] [Abstract][Full Text] [Related]
10. Etoposide targets topoisomerase IIalpha and IIbeta in leukemic cells: isoform-specific cleavable complexes visualized and quantified in situ by a novel immunofluorescence technique. Willmore E; Frank AJ; Padget K; Tilby MJ; Austin CA Mol Pharmacol; 1998 Jul; 54(1):78-85. PubMed ID: 9658192 [TBL] [Abstract][Full Text] [Related]
11. Transfection of human topoisomerase II alpha into etoposide-resistant cells: transient increase in sensitivity followed by down-regulation of the endogenous gene. Asano T; An T; Mayes J; Zwelling LA; Kleinerman ES Biochem J; 1996 Oct; 319 ( Pt 1)(Pt 1):307-13. PubMed ID: 8870683 [TBL] [Abstract][Full Text] [Related]
12. Enhanced topoisomerase I activity and increased topoisomerase II alpha content in cisplatin-resistant cancer cell lines. Minagawa Y; Kigawa J; Irie T; Kanamori Y; Itamochi H; Cheng X; Terakawa N Jpn J Cancer Res; 1997 Dec; 88(12):1218-23. PubMed ID: 9473741 [TBL] [Abstract][Full Text] [Related]
13. [Sensitivity to etoposide of human malignant glioma cell lines. Mechanisms of action]. Beauchesne P; Bonner JA; Mornex F; Brunon J Cancer Radiother; 1999; 3(1):57-64. PubMed ID: 10083864 [TBL] [Abstract][Full Text] [Related]
14. Induction of sensitivity to doxorubicin and etoposide by transfection of MCF-7 breast cancer cells with heregulin beta-2. Harris LN; Yang L; Tang C; Yang D; Lupu R Clin Cancer Res; 1998 Apr; 4(4):1005-12. PubMed ID: 9563896 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of topoisomerase IIalpha expression by transforming growth factor-beta1 is abrogated by the papillomavirus E7 protein. Satterwhite DJ; White RL; Matsunami N; Neufeld KL Cancer Res; 2000 Dec; 60(24):6989-94. PubMed ID: 11156401 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical and two-parameter flow cytometric studies of DNA topoisomerase II alpha in human epithelial ovarian carcinoma and germ cell tumor. Tanoguchi K; Sasano H; Yabuki N; Kikuchi A; Ito K; Sato S; Yajima A Mod Pathol; 1998 Feb; 11(2):186-93. PubMed ID: 9504690 [TBL] [Abstract][Full Text] [Related]
17. Complex response of breast epithelial cell lines to topoisomerase inhibitors. Davis PL; Shaiu WL; Scott GL; Iglehart JD; Hsieh TS; Marks JR Anticancer Res; 1998; 18(4C):2919-32. PubMed ID: 9713486 [TBL] [Abstract][Full Text] [Related]
18. Topoisomerase II alpha content and topoisomerase II catalytic activity cannot explain drug sensitivities to topoisomerase II inhibitors in lung cancer cell lines. Yamazaki K; Isobe H; Hanada T; Betsuyaku T; Hasegawa A; Hizawa N; Ogura S; Kawakami Y Cancer Chemother Pharmacol; 1997; 39(3):192-8. PubMed ID: 8996519 [TBL] [Abstract][Full Text] [Related]
19. Relationship of DNA topoisomerase II alpha and beta expression to cytotoxicity of antineoplastic agents in human acute lymphoblastic leukemia cell lines. Brown GA; McPherson JP; Gu L; Hedley DW; Toso R; Deuchars KL; Freedman MH; Goldenberg GJ Cancer Res; 1995 Jan; 55(1):78-82. PubMed ID: 7805045 [TBL] [Abstract][Full Text] [Related]
20. Topotecan increases topoisomerase IIalpha levels and sensitivity to treatment with etoposide in schedule-dependent process. Whitacre CM; Zborowska E; Gordon NH; Mackay W; Berger NA Cancer Res; 1997 Apr; 57(8):1425-8. PubMed ID: 9108439 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]